New Diabetes Drugs Invokana and Vipidia Launched in UKNew Diabetes Drugs Invokana and Vipidia Launched in UK

Two new oral drugs for the treatment of type 2 diabetes have been launched in the United Kingdom: the SGLT2 inhibitor canagliflozin and the DPP-4 inhibitor alogliptin. Medscape Medical News

Source: Medscape Diabetes Headlines - February 28, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news